SSY Group Limited (SEHK: 2005)
Health Care · Pharmaceuticals · HK
HK$2.67
-3.96% today · -10.6% 1Y
SSY Group Limited (SEHK: 2005) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $981.92M and employs 5,400 people.
Over the last twelve months the share price has lost 10.6%, trading between 2.01 and 3.18.
Tweenvest scores SSY Group Limited across four factors: quality 68/100, value 46/100, growth 15/100, dividend 92/100. Its strongest factor is dividend.
2005 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $981.92M
- Revenue (TTM)
- $558.38M
- P/E
- 15.26
- EPS
- 0.17
- Dividend yield
- 2.88%
- Beta (5Y)
- 0.48
- 52-week high
- HK$3.18
- 52-week low
- HK$2.01
- Avg volume (3M)
- —
- Shares outstanding
- 2.89B
- Employees
- 5,400
- Next earnings
- —
About SSY Group Limited
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
- ISIN
- KYG8406X1034
- Founded
- 1999
- Listed since
- Dec 20, 2005
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sunflower Pharmaceutical Group Co., Ltd.SZSE: 002737 | $1.01B | CN¥11.53 | +2.22% |
| Suzhou Highfine Biotech Co., Ltd.SZSE: 301393 | $998.51M | CN¥62.40 | -7.05% |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.SEHK: 1349 | $992.60M | HK$2.55 | +0.59% |
| Cisen Pharmaceutical Co., Ltd.SHSE: 603367 | $992.29M | CN¥14.68 | +1.03% |
| Shanghai Haixin Group Co., Ltd.SHSE: 600851 | $979.53M | CN¥7.82 | -1.39% |
| Tchaikapharma High Quality Medicines ADBUL: THQM | $975.46M | €8.60 | +3.61% |
| Jenkem Technology Co., Ltd.SHSE: 688356 | $974.64M | CN¥107.90 | +1.40% |
| Kissei Pharmaceutical Co., Ltd.TSE: 4547 | $969.47M | ¥3,710.00 | +0.41% |
Figures last refreshed Oct 11, 2026.